Szilvia Szeghalmy

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND Myelofibrosis (MF) is characterized by accumulation of stromal cells and extracellular matrix. Progression of fibrosis is an important clinical issue and monitoring is required for new therapeutic approaches. Currently, the quantification is based on semiquantitative evaluation of reticulin silver stained slides. We recently reported that(More)
Recently a specific immunohistochemical method was introduced which may overcome these weaknesses of reticulin staining. Activated fibroblasts responsible for stromal proliferation are highlighted by increased PDGFR β expression, which can be presented by immunohistochemistry in bone marrow samples. Using this staining the pre-fibrotic stage can become(More)
  • 1